Top Markets
Coin of the day
GeneDx Holdings Corp. GeneDx Holdings Corp.

GeneDx Holdings Corp.

WGS
Classifica tra le azioni #5446
GeneDx Holdings Corp. functions as a health intelligence firm singularly... GeneDx Holdings Corp. functions as a health intelligence firm singularly focused on the individual patient. It aims to revolutionize healthcare delivery by deploying advanced artificial intelligence and machine learning capabilities. These sophisticated algorithms are applied to vast, longitudinal clinical and genomic datasets to construct comprehensive, dynamic models of human health, ultimately defining personalized, optimal pathways for each person's well-being. Through its exclusive Centrellis health intelligence platform, the company gains profound insights into both disease states and overall wellness, enabling it to furnish evidence-based solutions for the most critical medical challenges. Eric Schadt established the corporation in October 2015, and its principal offices are located in Stamford, Connecticut.
Prezzo delle azioni
$90.29
Ultima sincronizzazione: 2026-08-26
Capitalizzazione di mercato
$2.69B
Variazione (1 giorno)
3.30%
Variazione (1 anno)
-30.11%
Paese
US
Scambia GeneDx Holdings Corp. (WGS)

Categoria

Storico del rendimento da dividendi per GeneDx Holdings Corp. (WGS)
Il rendimento da dividendi (TTM) di GeneDx Holdings Corp. (simbolo azionario: WGS) al 2026 è: 0
Rendimento medio negli ultimi 5 anni: 0.00%
Storico del rendimento da dividendi per GeneDx Holdings Corp. (WGS) da 2026 a 2026
Rendimento da dividendi alla fine di ogni anno (TTM)
Anno Rendimento da dividendi Cambia
Non abbastanza dati per le date fornite.
Rendimenti da dividendi (TTM) di aziende simili o concorrenti